It is estimated that 2 million individuals in the United States have opioid use disorder (OUD) and an estimated 130 deaths from opioid overdose occur each day.1 However, it is estimated that only 20% to 40% of individuals with OUD receive medications such as buprenorphine, methadone, and naltrexone to treat this disorder.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Roy PJ, Stein MD. Offering Emergency Buprenorphine Without a Prescription. JAMA. 2019;322(6):501–502. doi:10.1001/jama.2019.8309
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: